ClinicalTrials.gg
RecruitingNCT05495490Updated Nov 19, 2026

Osseodensification Versus Osteotome Internal Sinus Lifting in Delayed Implant Placement

An interventional study of Osseodensification Internal Sinus Lift and Osteotome Internal Sinus Lift in Maxillary Sinus Floor Augmentation, sponsored by Ain Shams University. Recruiting at 2 sites in Egypt. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by Ain Shams University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Feb 2026; still recruiting 9 months later.
Updated Nov 19, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

The sinus lift technique through alveolar crest Osseodensification is conservative, minimally invasive, and minimally traumatic, utilizing hydropneumatic counterclockwise rotating instruments to lift the maxillary sinus floor without touching the Schneiderian membrane, thereby minimizing the risk of perforation. In contrast, the internal sinus lift technique utilizing osteotomes to raise the Schneiderian membrane eliminated hammering, making the technique more patient-friendly, with the placement of a graft biomaterial around the implant. The challenge in this technique was the availability of > 5mm residual bone height preventing membrane perforation and low primary implant stability. Consequently, the investigator aims to compare the efficacy and clinical outcomes of Osseodensification and Osteotome internal sinus lifting after delayed implant placement by assessing bone gain and bone density around implants radiographically, the primary stability of the implants clinically, and patient satisfaction.

Read the detailed description

Twenty patients with maxillary posterior edentulous ridge will be randomly assigned to one of two equal groups: Osseodensification sinus lift using sticky bone as a graft material (Group 1) and Osteotome internal sinus lift using sticky bone as a graft material (Group 2). (Group 2). Using Cone Beam Computed Tomography (CBCT), the sinus anatomy and height and width of the residual ridge from the sinus floor to the alveolar crest of all patients will be evaluated prior to surgery. Each patient will then receive pre-surgical medication consisting of intravenous steroidal anti-inflammatory drug (dexamethasone sodium phosphate 4mg) one hour prior to the procedure and oral rinsing with 0.12 percent chlorhexidine for one minute. After surgery, patients will receive 14 days of twice-daily chlorhexidine rinses 0.12 percent for postoperative treatment. Patients allergic to penicillin are given 1 g amoxicillin twice daily for six days or 0.5 g azithromycin. Ibuprofen (400) should be administered three times daily unless medically contraindicated. After insertion, the primary stability of each implant will be evaluated using a torque wrench and an Osstell device. All patients will undergo immediate postoperative CBCTs to assess bone gain and bone density. Utilizing the Visual Analogue Scale, patients' pain will be evaluated (VAS). A health-related quality of life questionnaire will be used to evaluate the patients' perception of recovery in terms of pain, oral function, general activity, and other symptoms. Postoperatively, the operator's subjective satisfaction with Osseodensification and Osteotome sinus lift techniques will be evaluated using a second printed questionnaire.

02

Conditions studied

  • Maxillary Sinus Floor Augmentation

Keywords

  • Osseodensification
  • Osteotome
  • Internal Sinus Lifting
  • Sticky Bone
03

In context

Lead sponsor

Ain Shams University is the lead sponsor of 1,958 studies on the registry; 432 are open to participants now.

Of its 35 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 1. Patient partially edentulous with maxillary posterior edentulous ridge after extraction of more than 4 months.

    2. Both sexes will be selected males and females.

    3. Adult patients aged between 18 and 40 years of age.

    4. Good general health (American Society of Anesthesiology Physical Status Ⅰ-Ⅱ).

    5. Initial residual alveolar ridge height ranging between 4 to 6 mm according to preoperative CBCT.

    6. No previous surgery or radiation treatment on the maxillary sinus.

Exclusion criteria

Exclusion Criteria:

  • 1. Smokers.

    2. Pregnant or lactating females.

    3. Psychiatric disorders.

    4. Uncontrolled systemic disease.

    5. Hematologic diseases and coagulation disorders.

    6. Chemotherapy or radiotherapy of the head and neck area, and status.

    7. Medical conditions affecting bone metabolism and ongoing treatment with bisphosphonates drugs or systemic .

    8. Presence of acute or chronic sinus pathoses or sinus membrane perforation.

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Osseodensification Internal Sinus Lift / Sticky Bone graft material

    Osseodensification Internal Sinus Lift will be performed using sticky bone as a graft material.

    Procedure: Osseodensification Internal Sinus Lift

  • Active comparator
    Osteotome Internal Sinus Lift /Sticky Bone graft material

    Osteotome Internal Sinus Lift will be performed using sticky bone as a graft material.

    Procedure: Osteotome Internal Sinus Lift

Interventions

  • ProcedureOsseodensification Internal Sinus Lift

    The osteotomy for the Osseodensification internal sinus lift begins with the advancement of a twist drill at 800 rpm and saline irrigation to within 1-2 mm of the sinus floor. The osteotomy is then widened by employing a series of osteotomy drills rotating at 800 rpm. Infracture of the sinus has occurred when the final osteotomy drill is advanced with gentle pressure at 100 rpm counterclockwise without irrigation until a bouncing sensation ("haptic feedback") occurs. After infracture, the graft material will be injected into the osteotomy site. Using the final osteotomy drill, the graft is guided apically. This procedure is repeated incrementally to raise the membrane. Once sufficient space has been created beneath the antral membrane, the implant will be inserted followed by suturing.

  • ProcedureOsteotome Internal Sinus Lift

    The osteotomy for the Osteotome internal sinus lift will begin with standard drills and saline irrigation to prepare the implant socket with a working length that is 1-2 mm shorter than the residual bone height as determined by radiographic examination. After preparation, a series of osteotomes of varying diameters will be sequentially utilized to widen the osteotomy and elevate the Schneiderian membrane by vertical tapping to create a "greenstick" fracture. The Valsalva maneuver (nasal blowing test) will be performed to determine the integrity of the Schneiderian membrane. During the osteotomy, the graft material will be injected and slowly placed into the elevated space using osteotomes until the desired depth is reached. Implant placement and suturing will conclude the procedure.

    Also known as: Bone-Added Osteotome Sinus Floor Elevation Technique, Summers Osteotome Technique

06

What researchers measure

Primary outcomes

  1. Radiographic Assessment of Change in the Vertical Bone Height (Bone Gain).

    The outcome will be obtained by the aid of Computed Cone Beam Tomography, assessing the amount of change from the pre-operative to the post-operative vertical bone height in millimeters.

    Time frame: Pre-operative and Immediately post-operative.

  2. Radiographic Assessment of Change in the Bone Density.

    The outcome will be obtained by the aid of Computed Cone Beam Tomography assessing the amount of change from the pre-operative to the post-operative bone density values in Hounsfield unit.

    Time frame: Pre-operative and Immediately post-operative.

Secondary outcomes

  1. Clinical Assessment of Primary Stability of the Implants ( Insertion Torque Value) Measured by a Torque Wrench.

    The outcome will be obtained by the aid of a torque wrench and recorded in Newton centimeters. ( low torque (\<30), medium torque (30 \< Insertion Torque \< 50), and high torque (\>50).

    Time frame: During procedure.

  2. Clinical Assessment of Primary Stability of the Implants (Implant Stability Quotient ) Measured by an Osstell® Device.

    The outcome will be obtained by the aid of an Osstell device, measured by the Resonance Frequency Analysis and determined by the Implant Stability Quotient ( within a 0-100 scale; 100 being maximum implant stability) .

    Time frame: During procedure.

  3. Patient's Post-Operative Pain Assessment

    The outcome will be obtained by the aid of a 100 mm Visual Analogue Scale (0 = minimal to; 100 = maximum)

    Time frame: 1 week post-operative

  4. Patient's Satisfaction Assessment.

    The outcome will be obtained by the aid of a health-related quality of life questionnaire designed to assess the patient's perception of recovery concerning pain, oral function, general activity, and other symptoms.

    Time frame: 1 week post-operative

  5. Operator's Satisfaction Assessment

    The outcome will be obtained by the aid of a a questionnaire assessing the operator's satisfaction with Osseodensification and Osteotome sinus lift techniques.

    Time frame: 1 year

07

Study locations

2 of 2 sites recruiting
08

References and documents

Publications

  • Huwais S, Mazor Z, Ioannou AL, Gluckman H, Neiva R. A Multicenter Retrospective Clinical Study with Up-to-5-Year Follow-up Utilizing a Method that Enhances Bone Density and Allows for Transcrestal Sinus Augmentation Through Compaction Grafting. Int J Oral Maxillofac Implants. 2018 Nov/Dec;33(6):1305-1311. doi: 10.11607/jomi.6770. PubMed 30427961 ↗
  • Pjetursson BE, Lang NP. Sinus floor elevation utilizing the transalveolar approach. Periodontol 2000. 2014 Oct;66(1):59-71. doi: 10.1111/prd.12043. PubMed 25123761 ↗
  • Danesh-Sani SA, Loomer PM, Wallace SS. A comprehensive clinical review of maxillary sinus floor elevation: anatomy, techniques, biomaterials and complications. Br J Oral Maxillofac Surg. 2016 Sep;54(7):724-30. doi: 10.1016/j.bjoms.2016.05.008. Epub 2016 May 25. PubMed 27235382 ↗
  • Mourao CF, Valiense H, Melo ER, Mourao NB, Maia MD. Obtention of injectable platelets rich-fibrin (i-PRF) and its polymerization with bone graft: technical note. Rev Col Bras Cir. 2015 Nov-Dec;42(6):421-3. doi: 10.1590/0100-69912015006013. English, Portuguese. PubMed 26814997 ↗
  • Gheno E, Alves GG, Ghiretti R, Mello-Machado RC, Signore A, Lourenco ES, Leite PEC, Mourao CFAB, Sohn DS, Calasans-Maia MD. "Sticky Bone" Preparation Device: A Pilot Study on the Release of Cytokines and Growth Factors. Materials (Basel). 2022 Feb 16;15(4):1474. doi: 10.3390/ma15041474. PubMed 35208017 ↗
  • Zhou X, Hu XL, Li JH, Lin Y. Minimally Invasive Crestal Sinus Lift Technique and Simultaneous Implant Placement. Chin J Dent Res. 2017;20(4):211-218. doi: 10.3290/j.cjdr.a39220. PubMed 29181458 ↗
  • Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007 May;39(2):175-91. doi: 10.3758/bf03193146. PubMed 17695343 ↗

Individual participant data

Plan to share: Yes — Individual participant data that underlie the results reported in this article after deidentification. (Text, tables, figures and appendices).

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: Immediately following publication. No end date.

Access criteria: Investigators whose proposed use of the data has been approved by an independent review committee ("learned intermediary identified for this purpose")

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Feb 2026 (actual). Primary completion is estimated for Aug 2027, 18 months after the start.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 19, 2026: primary completion Mar 2027 → Aug 2027 and completion Apr 2027 → Oct 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 5, 2022
First posted
Aug 10, 2022
StartActual
Feb 10, 2026
Primary completionEst.
Aug 21, 2027was Mar 2027
CompletionEst.
Oct 21, 2027was Apr 2027
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Mar 21, 2027→Aug 21, 2027
Nov 19, 2026
Study completion
Apr 21, 2027→Oct 21, 2027
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    Primary completion Mar 21, 2027→Aug 21, 2027
    Study completion Apr 21, 2027→Oct 21, 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05495490
Responsible party
Omneya M. Elkadi (Assistant Lecturer, Ain Shams University) — Principal investigator
First posted
Aug 10, 2022
Start date
Feb 10, 2026
Primary completion
Aug 21, 2027 (estimated)
Completion
Oct 21, 2027 (estimated)
Last update
Nov 19, 2026

Study contacts

Omneya M. Elkadi, Ass.Lecturer
Contact
ninielkadi@gmail.com
00201121844448
Hala A. Abuel- Ela, Professor
study director · Faculty of Dentistry- Ain Shams University
Mohamed W. Bissar, Lecturer
study director · Faculty of Dentistry- Ain Shams University
Omneya M. Elkadi
principal investigator · Faculty of Dentistry- Ain Shams University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion